1Yang W,Lu J,Weng J.China national diabetes and metabolic disorders study group. Prevalence of diabetes among men and women in China[J].N Engl J Med, 2010,362(12) : 1090-1101.
8Nissen SE,Wolski K.Effect of Rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes [J].NEngl J Meal,2007,356(24) :2457-2471.
4Malone DC, Boudreau DM, Nichols GA, et al. Association of cardiometabolic risk factors and prevalent cardiovascular events [ J ].Metab Syndr Relat Disord, 2009,7 (6) : 585-593.
5Diep QN, Schiffrin EL. Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats [J]. Hypertension, 2001,38 (2) : 249-254.
6Orasanu G, Ziouzenkova O, Devchand PR, et al. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice [J]. J Am Coll Cardiol, 2008,52 (10) :869-881.